Live
FierceBiotechScaling theranostics through access, safety and trustEndpoints NewsUCB bets $2 billion on Candid's T cell engager ambitionsIlluminaWilkins Investment Counsel Inc. Trims Stake in Illumina, Inc. $ILMN - MarketBeatSamsung Biologics(LEAD) Samsung Biologics labor union set to resume talks with management on Monday - Yonhap News Agency10x Genomics News10x Genomics stock up on Atera launch, spatial biology scale enhanced - MSNBio-RadBio-Rad expands antibody portfolio for biologics bioanalysis and drug monitoring - Laboratory TalkSamsung BiologicsFirst strikes in Samsung Biologics' 15-year history put labor relations to test - The Korea Herald10x Genomics NewsShould Launch of Atera Spatial Biology Platform Require Action From 10x Genomics (TXG) Investors? - Yahoo Finance UK10x Genomics BlogShould Launch of Atera Spatial Biology Platform Require Action From 10x Genomics (TXG) Investors? - Yahoo FinanceGE HealthCareGE HealthCare Venue Family: How POCUS supports clinicians where they work - gehealthcare.comVertexBank of America Names Vertex Pharmaceuticals Top Biotech Pick for 2026 - HarianBasis.coVertexVertex (VRTX) Named Top Biotech Pick for 2026 by BofA - Yahoo Finance
FierceBiotech Mar 20, 2026

Embecta to buy auto-injector maker Owen Mumford for $200M to diversify beyond insulin

Embecta to buy auto-injector maker Owen Mumford for $200M to diversify beyond insulin

Original
Body unavailable. Use the original source.